Griñán-Ferré, Christian
Codony, Sandra
Pujol, Eugènia
Yang, Jun
Leiva, Rosana
Escolano, Carmen
Puigoriol-Illamola, Dolors
Companys-Alemany, Júlia
Corpas, Rubén
Sanfeliu, Coral
Pérez, Belen
Loza, M. Isabel
Brea, José
Morisseau, Christophe
Hammock, Bruce D.
Vázquez, Santiago
Pallàs, Mercè
Galdeano, Carles
Funding for this research was provided by:
Ministerio de Economía, Industria y Competitividad, Gobierno de España (SAF2017-82771, SAF2016-77703, SAF2015-68749, Innopharma Project)
Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (2017 SGR 106)
Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (ED431C 2018/21)
National Institute of Environmental Health Sciences (R01 ES002710, P42 ES004699)
This article is maintained by: Elsevier
Article Title: Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00854-1
Content Type: article
Copyright: Copyright © 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.